For women requiring diabetes management during breastfeeding, alternative agents such as insulin or metformin may be considered under specialist supervision
Witt S, Kristensen K, Hohenfellner K, Quitmann J (2023) Health-related quality of life and patient-reported outcome measurements in patients with cystinosis
After your first Semaglutide (GLP-1) injection, its common to experience mild changes as your body begins adjusting to the medication
References Product warnings updated for GLP-1 RA class, 01 December 2025, Therapeutic Good Administrations, GLP-1 RAs: warnings aligned over potential risk of suicidal thoughts or behaviours, 01 December 2025, Therapeutic Good Administration, Updated contraception advice for Mounjaro (tirzepatide), 01 December 2025, Therapeutic Good Administrations, GLP-1 medicines for weight loss and diabetes: what you need to know, 20 August 2025, Medicine and Healthcare Product Regulatory Agency, Australias drug regulator issues mental health warning for weight-loss drugs including Ozempic, 01 December 2025,
These policy discussions remain preliminary and would not affect private access through licensed compounding pharmacies like those PlexusDx partners with